Breast Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head & Neck Cancer, Urothelial Carcinoma

Applying the 20X Rule for Scoring CPS

In this PD-L1 IHC 22C3 pharmDx Tutorial Video, you will learn to:​

  • Confidently determine which mononuclear inflammatory cells (MICs) should be included in Combined Positive Score (CPS) evaluation​
  • Understand and consistently apply the 20X rule in various scenarios​

 

Agilent’s PD-L1 IHC 22C3 pharmDx tutorial videos are an engaging and easy to understand resource for advancing your knowledge of Tumor Proportion Score (TPS) and Combined Positive Score (CPS) interpretation. Through these trainings we will help you to confidently:

  • Understand inclusion/exclusion criteria and other core principles of TPS and CPS
  • Improve cellular quantification techniques
  • Navigate challenging morphology and staining characteristics
  • Apply helpful strategies for assessing the appropriate TPS or CPS

Related Training

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.​D0113775_1.00